Most bought healthcare stocks in Q1 2019
See which Healthcare stocks institutional investors increased the most in Q1 2019, measured as net growth in reported share positions from Q4 2018 into Q1 2019. Notable additions at the top of this list include TAKEDA PHARMACEUTIC-SP ADR (TAK), BRISTOL-MYERS SQUIBB CO (BMY), GILEAD SCIENCES INC (GILD), BOSTON SCIENTIFIC CORP (BSX). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 10,852,990 | $228.90K | 1 | 1 | 0 | 0 | 2 |
| BMY | BRISTOL-MYERS SQUIBB CO | 8,733,434 | $23.20M | 2 | 3 | 3 | 1 | 9 |
| GILD | GILEAD SCIENCES INC | 5,775,611 | $462.58K | 1 | 6 | 0 | 0 | 7 |
| BSX | BOSTON SCIENTIFIC CORP | 5,189,405 | $215.58K | 2 | 0 | 2 | 0 | 4 |
| ABBV | ABBVIE INC | 4,058,497 | $323.52K | 1 | 3 | 3 | 1 | 8 |
| ELAN | ELANCO ANIMAL HEALTH INC | 3,928,752 | $126.00K | 2 | 0 | 0 | 0 | 2 |
| EXEL | EXELIXIS INC | 3,660,766 | $111.57K | 1 | 1 | 0 | 0 | 2 |
| CVS | CVS HEALTH CORP | 3,523,643 | -$242.72K | 0 | 5 | 3 | 1 | 8 |
| PFE | PFIZER INC | 3,475,781 | -$536.05K | 2 | 2 | 7 | 0 | 11 |
| CNC | CENTENE CORP | 3,343,679 | $91.81K | 0 | 3 | 1 | 0 | 4 |
| SAVA | CASSAVA SCIENCES INC | 2,280,073 | $2.94K | 2 | 0 | 0 | 0 | 2 |
| BKD | BROOKDALE SENIOR LIVING INC | 2,161,897 | $13.60K | 0 | 1 | 0 | 0 | 1 |
| ALGN | ALIGN TECHNOLOGY INC | 1,773,997 | $943.17K | 1 | 5 | 1 | 0 | 7 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 1,742,100 | $191.75K | 1 | 0 | 1 | 0 | 2 |
| EDIT | EDITAS MEDICINE INC | 1,634,345 | $47.15K | 0 | 2 | 0 | 0 | 3 |
| MYGN | MYRIAD GENETICS INC | 1,511,931 | $55.73K | 0 | 1 | 0 | 0 | 1 |
| JNJ | JOHNSON & JOHNSON | 1,284,365 | $329.74K | 0 | 6 | 5 | 0 | 14 |
| GOSS | GOSSAMER BIO INC | 1,267,171 | $26.11K | 1 | 0 | 0 | 0 | 1 |
| MCRB | SERES THERAPEUTICS INC | 1,265,534 | $20.27K | 0 | 2 | 0 | 0 | 2 |
| ELV | ELEVANCE HEALTH INC | 1,166,477 | $543.85K | 1 | 4 | 4 | 0 | 9 |
| CERS | CERUS CORP | 1,159,851 | $15.04K | 1 | 1 | 0 | 0 | 2 |
| HROW | HARROW INC | 967,806 | $4.82K | 1 | 0 | 0 | 0 | 1 |
| NTLA | INTELLIA THERAPEUTICS INC | 951,246 | $40.36K | 0 | 1 | 0 | 1 | 1 |
| LAB | STANDARD BIOTOOLS INC | 914,200 | $17.95K | 0 | 1 | 0 | 0 | 1 |
| BIIB | BIOGEN INC | 905,288 | $125.06K | 1 | 3 | 0 | 1 | 5 |
| SGMO | SANGAMO THERAPEUTICS INC | 905,200 | $8.64K | 1 | 0 | 0 | 0 | 1 |
| XRAY | DENTSPLY SIRONA INC | 876,969 | $137.02K | 0 | 2 | 1 | 1 | 3 |
| ZTS | ZOETIS INC | 821,121 | $319.62K | 0 | 3 | 1 | 0 | 5 |
| CMRX | CHIMERIX INC | 762,515 | $1.34K | 0 | 1 | 0 | 0 | 1 |
| INCY | INCYTE CORP | 761,008 | $164.16K | 0 | 3 | 0 | 0 | 3 |
| VRTX | VERTEX PHARMACEUTICALS INC | 744,417 | $215.99K | 0 | 1 | 0 | 0 | 1 |
| PCRX | PACIRA BIOSCIENCES INC | 708,300 | $25.20K | 0 | 1 | 0 | 0 | 1 |
| APYX | APYX MEDICAL CORP | 676,107 | $4.27K | 1 | 0 | 0 | 0 | 1 |
| GMAB | GENMAB A/S -SP ADR | 658,895 | $11.54K | 0 | 1 | 0 | 0 | 1 |
| MCK | MCKESSON CORP | 642,785 | $143.72K | 1 | 2 | 3 | 1 | 6 |
| MGNX | MACROGENICS INC | 627,623 | $12.32K | 0 | 1 | 0 | 0 | 1 |
| HCA | HCA HEALTHCARE INC | 626,490 | $96.49K | 0 | 1 | 1 | 0 | 2 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | 614,580 | $161.79K | 0 | 2 | 0 | 0 | 2 |
| BHC | BAUSCH HEALTH COS INC | 610,685 | $180.62K | 1 | 1 | 1 | 0 | 5 |
| DHR | DANAHER CORP | 571,891 | $495.63K | 0 | 3 | 3 | 0 | 7 |
| TMO | THERMO FISHER SCIENTIFIC INC | 559,979 | $309.78K | 0 | 2 | 8 | 0 | 11 |
| CLDX | CELLDEX THERAPEUTICS INC | 545,106 | $2.68K | 1 | 0 | 0 | 0 | 1 |
| PINC | PREMIER INC-CLASS A | 494,960 | $10.21K | 0 | 2 | 0 | 0 | 2 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 492,547 | $1.37K | 0 | 1 | 0 | 0 | 1 |
| HALO | HALOZYME THERAPEUTICS INC | 442,300 | $10.81K | 0 | 1 | 1 | 0 | 4 |
| LNTH | LANTHEUS HOLDINGS INC | 427,800 | $19.37K | 0 | 1 | 0 | 0 | 1 |
| CORT | CORCEPT THERAPEUTICS INC | 410,600 | -$2.71K | 0 | 1 | 0 | 0 | 1 |
| IQV | IQVIA HOLDINGS INC | 387,147 | $323.33K | 0 | 1 | 0 | 0 | 3 |
| EBS | EMERGENT BIOSOLUTIONS INC | 382,391 | $5.34K | 0 | 1 | 0 | 0 | 1 |
| HSIC | HENRY SCHEIN INC | 375,696 | $22.52K | 1 | 0 | 0 | 1 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q1 2019
What are the most bought Healthcare stocks in Q1 2019?
The most bought healthcare stocks in Q1 2019 are those with the largest increase in reported share counts across tracked institutional investors compared to Q4 2018, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q1 2019?
Among the managers we track, net additions were largest in companies such as TAKEDA PHARMACEUTIC-SP ADR (TAK), BRISTOL-MYERS SQUIBB CO (BMY), GILEAD SCIENCES INC (GILD), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q4 2018).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.